ALKS
Price
$27.00
Change
-$0.20 (-0.74%)
Updated
Apr 17 closing price
Capitalization
4.55B
4 days until earnings call
VTRS
Price
$7.56
Change
+$0.17 (+2.30%)
Updated
Apr 17 closing price
Capitalization
14.18B
19 days until earnings call
Ad is loading...

ALKS vs VTRS

Header iconALKS vs VTRS Comparison
Open Charts ALKS vs VTRSBanner chart's image
Alkermes
Price$27.00
Change-$0.20 (-0.74%)
Volume$1.7M
Capitalization4.55B
Viatris
Price$7.56
Change+$0.17 (+2.30%)
Volume$10.72M
Capitalization14.18B
ALKS vs VTRS Comparison Chart
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. VTRS commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a StrongBuy and VTRS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (ALKS: $27.00 vs. VTRS: $7.56)
Brand notoriety: ALKS and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 88% vs. VTRS: 68%
Market capitalization -- ALKS: $4.55B vs. VTRS: $14.18B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 2 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • ALKS’s FA Score: 2 green, 3 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, ALKS is a better buy in the long-term than VTRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 4 bullish, 5 bearish.
  • VTRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а +1.54% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +4.13% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.78%. For the same industry, the average monthly price growth was -5.82%, and the average quarterly price growth was -13.07%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 23, 2025.

VTRS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than ALKS($4.55B). VTRS has higher P/E ratio than ALKS: VTRS (238.80) vs ALKS (8.90). ALKS YTD gains are higher at: -6.120 vs. VTRS (-38.513). VTRS has higher annual earnings (EBITDA): 3.52B vs. ALKS (519M). VTRS has more cash in the bank: 1.18B vs. ALKS (773M). ALKS has less debt than VTRS: ALKS (372M) vs VTRS (18.4B). VTRS has higher revenues than ALKS: VTRS (15.4B) vs ALKS (1.66B).
ALKSVTRSALKS / VTRS
Capitalization4.55B14.2B32%
EBITDA519M3.52B15%
Gain YTD-6.120-38.51316%
P/E Ratio8.90238.804%
Revenue1.66B15.4B11%
Total Cash773M1.18B65%
Total Debt372M18.4B2%
FUNDAMENTALS RATINGS
ALKS vs VTRS: Fundamental Ratings
ALKS
VTRS
OUTLOOK RATING
1..100
6360
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
24100
SMR RATING
1..100
3691
PRICE GROWTH RATING
1..100
5965
P/E GROWTH RATING
1..100
121
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (12) in the null industry is significantly better than the same rating for ALKS (99) in the Biotechnology industry. This means that VTRS’s stock grew significantly faster than ALKS’s over the last 12 months.

ALKS's Profit vs Risk Rating (24) in the Biotechnology industry is significantly better than the same rating for VTRS (100) in the null industry. This means that ALKS’s stock grew significantly faster than VTRS’s over the last 12 months.

ALKS's SMR Rating (36) in the Biotechnology industry is somewhat better than the same rating for VTRS (91) in the null industry. This means that ALKS’s stock grew somewhat faster than VTRS’s over the last 12 months.

ALKS's Price Growth Rating (59) in the Biotechnology industry is in the same range as VTRS (65) in the null industry. This means that ALKS’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as ALKS (12) in the Biotechnology industry. This means that VTRS’s stock grew similarly to ALKS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSVTRS
RSI
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
63%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
64%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 6 days ago
67%
Declines
ODDS (%)
Bearish Trend 12 days ago
62%
Bearish Trend 4 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
61%
Aroon
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
69%
View a ticker or compare two or three
Ad is loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with ESPR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then ESPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-0.74%
ESPR - ALKS
35%
Loosely correlated
-1.44%
DVAX - ALKS
32%
Poorly correlated
-3.19%
PRGO - ALKS
31%
Poorly correlated
+0.72%
VTRS - ALKS
30%
Poorly correlated
+2.30%
COLL - ALKS
30%
Poorly correlated
-0.04%
More

VTRS and

Correlation & Price change

A.I.dvisor tells us that VTRS and ZTS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTRS and ZTS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+2.30%
ZTS - VTRS
32%
Poorly correlated
+1.30%
PRGO - VTRS
31%
Poorly correlated
+0.72%
AMRX - VTRS
31%
Poorly correlated
+2.51%
ALKS - VTRS
30%
Poorly correlated
-0.74%
PBH - VTRS
30%
Poorly correlated
+0.60%
More